Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)-will there ever be enough data?

Ann Transl Med. 2023 Apr 28;11(8):293. doi: 10.21037/atm-23-205. Epub 2023 Feb 27.

Authors

Harry Crane¹, Mark Danta^{1

2}

Affiliations

¹ Department of Gastroenterology and Hepatology, St Vincent's Hospital, Sydney, Australia.
² School of Clinical Medicine, St Vincent's Healthcare Clinical Campus, Faculty of Medicine, UNSW, Sydney, Australia.

No abstract available

Keywords: Aspirin; chronic hepatitis B (CHB); hepatocellular carcinoma (HCC); prevention.

Publication types

Editorial
Comment